Hints and tips:
...Wickr’s investors include venture capitalists Gilman Louie, who used to run In-Q-Tel, the CIA’s VC fund, and Jim Breyer, an early Facebook investor, both of whom serve on the board....
...Wickr’s list of investors include Michele Burns, who is on the board of directors for Goldman Sachs, Gilman Louie, the founder and former chief executive of In-Q-Tel, the CIA’s strategic venture fund, and...
...Mr Gilman’s credibility was at the centre of the arguments. Mr Martoma’s lawyer focused on Mr Gilman’s “evolving memory” that he said he changed to fit the documents....
...I may have with others,” Mr Gilman testified. Mr Martoma’s lawyers are expected to emphasise holes in Mr Gilman’s memory....
...He attacked Mr Gilman’s credibility, telling the jury his story had changed several times from when he was first approached by prosecutors....
...Mr Gilman is expected to testify later in the case....
...Prosecutors said they are not able to locate that email because the University of Michigan, where Dr Gilman worked, did not retain email records....
...In July 2008, after Mr Gilman received the final trial results, he testified that he gave them to Mr Martoma, who flew to Michigan to meet him....
...After learning that the drug trial was disappointing on Thursday July 17 2008, Dr Gilman is expected to testify that he called Mr Martoma and relayed the results during a nearly two-hour conversation....
...Dr Gilman has struck a non-prosecution deal. As a result of the “illegal trades” the SEC said SAC made profits and avoided losses of more than $275m....
...Dr Gilman is co-operating with authorities. Mr Martoma has pleaded not guilty....
...Mr Gilman has an immunity deal with prosecutors and is co-operating with the case against Mr Martoma....
...Last autumn, Dr Gilman agreed to co-operate and on November 15 struck a non-prosecution agreement, an unusual arrangement allowing Dr Gilman, now 80-years-old, to avoid prosecution in exchange for his truthful...
...Although it is expected to withhold an encryption key, the school is close to a deal allowing the government to run keyword searches on files of Dr Sidney Gilman, who allegedly gave confidential drug trial...
...The battle over the files of Dr Sidney Gilman, a former professor of neurology at the medical school, has become pivotal in the government’s investigation of a former SAC Capital employee, Mathew Martoma...
...US authorities allege Mr Martoma was briefed multiple times by Sidney Gilman, the doctor on the committee overseeing the trial, between 2006 and July 2008. The SEC sued Mr Gilman and CR Intrinsic....
...The Securities and Exchange Commission says Dr Sid Gilman, professor of neurology at the University of Michigan Medical School, passed sensitive information to Matthew Martoma, a fund manager....
...Refiner Tesoro put on 5.9 per cent to $21.30 after Benchmark Company analyst Mark Gilman upgraded the company, and predicted Tesoro will reinstate its 40 cent annual dividend, suspended in 2009....
International Edition